Back to search

Switzerland· 68254004

Sitagliptin Zentiva 50 mg, Filmtabletten

A sitagliptin product containing sitagliptinum, registered in Switzerland by Helvepharm AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC A10BH01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedSitagliptin Zentiva 50 mg, Filmtable…ATCA10BH01REGISTER NO.68254004PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Sitagliptin is registered in 19 of 19 countries.

Countries holding a registration under ATC A10BH01 (sitagliptin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 11 of them publish a price we can compare per daily dose

Sitagliptin · ATC A10BH01

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sitagliptin costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.65 in France to $5.47 in Switzerland — a ×8.4 gap.

  • Switzerland: $5.47 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Sitagliptin · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$5.47
  • IT Italy$1.78
  • ES Spain$1.08
  • FR France$0.65
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
sitagliptinum
Manufacturer
Helvepharm AG
Country
Switzerland (CH)
ATC code
A10BH01
ATC class
Sitagliptin
Defined daily dose
0.1 g, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680682540044
    98 Stk
    CHF 70

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

341 interactions on record for sitagliptin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Sitagliptin · interactions on record

341 records

  • 3 severe
  • 292 moderate
  • 44 minor

Most severe, free to view

  • GatifloxacinJ01MA16severe
  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sitagliptin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sitagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Jansitin, Jazeta
  • Belgium · Sitagliptin Eg, Sitagliptin Grindeks
  • Bulgaria · Sitagliptin Grindeks, Майсиглу
  • Cyprus · Jidinum, Jimandin
  • Czechia · Anau, Ansifora
  • Germany · Frekidir, Jansitin
  • Denmark · Frekidir, Meliglix
  • Estonia · Adimuplan, Maysiglu
  • Spain · Altuxerin, Disit
  • Finland · Sitagliptin Apc Instytut, Sitagliptin Ashcure
  • France · Sitagliptine Adamed, Sitagliptine Almus
  • United Kingdom (Northern Ireland) · Sitagliptin, Sitagliptin Amarox
  • Greece · Adimuplan, Axavel
  • Croatia · Adimuplan, Condias
  • Hungary · Ansifora, Jaglix
  • Ireland · Sitagliptin Grindeks, Sitagliptin Krka
  • Iceland · Januvia, Ristaben
  • Italy · Adaglip, Andamane
  • Liechtenstein · Januvia, Ristaben
  • Lithuania · Adimuplan, Jimandin
  • Luxembourg · Sitagliptin Eg
  • Latvia · Adimuplan, Jimandin
  • Malta · Anau, Jidinum
  • Netherlands · Adimuplan, Anau
  • Norway · Frekidir, Januvia
  • Poland · Ansifora, Jansitin
  • Portugal · Itam, Jidinum
  • Romania · Adimuplan, Jansitin
  • Sweden · Axavel, Frekidir
  • Slovenia · Adimuplan, Maysiglu
  • Slovakia · Adimuplan, Anau

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d1e04da8-0c08-4766-b610-9c605d6434ab
GET /v1/drugs/d1e04da8-0c08-4766-b610-9c605d6434ab?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "sitagliptinum 50 mg",
  "valid_from": "2023-02-01",
  "limitations": "[{\"description\":\"Zur Behandlung von Patienten mit einem Typ 2 Diabetes mellitus, wenn Diät und vermehrte körperliche Aktivität nicht ausreichen:<br>\\n- Als Monotherapie, für Patienten, welche mit den bisherigen oralen Therapien nur ungenügend eingestellt werden können oder diese nicht vertragen.<br>\\n- Als Zweifachkombination ausschliesslich mit Metformin oder einem Sulfonylharnstoff, wenn mit Metformin oder Sulfonylharnstoff alleine keine ausreichende Kontrolle der Glykämie erreicht werden kann.<br>\\n- Als Dreifachkombination mit einer Kombination aus Metformin und einem Sulfonylharnstoff, wenn mit der Zweifachkombination mit diesen Substanzen keine ausreichende Kontrolle der Glykämie erreicht werden kann.<br>\\n- In Kombination mit Insulin (mit oder ohne Metformin), wenn durch diese Massnahmen keine ausreichende Kontrolle der Glykämie erreicht wird.<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2023-12-01\"}]",
  "galenic_form": "Filmtabl 50 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2023-02-01",
  "self_retention_pct": 10
}

See everything about sitagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.